Sagopilone

C30H41NO6S

Sagopilone, ZK-EPO, 305841-29-6, ZK-219477, DE-03757, EPO-477, SH-Y03757A, KY72JU32FO, BAY86-5302, ZK219477, ZK 219477, (1S,3S,7S,10R,11S,12S,16R)-10-allyl-7,11-dihydroxy-8,8,12,16-tetramethyl-3-(2-methylbenzo[d]thiazol-5-yl)-4,17-dioxabicyclo[14.1.0]heptadecane-5,9-dione, (1S,3S,7S,10R,11S,12S,16R)-7,11-dihydroxy-8,8,12,16-tetramethyl-3-(2-methyl-1,3-benzothiazol-5-yl)-10-prop-2-enyl-4,17-dioxabicyclo[14.1.0]heptadecane-5,9-dione, Sagopilone [USAN], Sagopilone [USAN:INN], UNII-KY72JU32FO, ZK epothilone, ZK-epothilone, Bay 86-5302, SH Y03757A, SH-Y-03757, BAY-86-5302, DE 03757, SAGOPILONE [INN], Sagopilone (USAN/INN), SAGOPILONE [WHO-DD], SCHEMBL423579, CHEMBL2304041, DTXSID30952866, CHEBI:177512, DB12391, A14328, D09721, Q27282501, (1S,3S,7S,10R,11S,12S,16R)-10-ALLYL-7,11-DIHYDROXY-8,8,12,16-TETRAMETHYL-3-(2-METHYL-1,3-BENZOTHIAZOL-5-YL)-4,17-DIOXABICYCLO(14.1.0)HEPTADECANE-5,9-DIONE, (1S,3S,7S,10R,11S,12S,16R)-10-ALLYL-7,11-DIHYDROXY-8,8,12,16-TETRAMETHYL-3-(2-METHYLBENZOTHIAZOL-5-YL)-4,17-DIOXABICYCLO(14.1.0)HEPTADECANE-5,9-DIONE, (1S,3S,7S,10R,11S,12S,16R)-7,11-DIHYDROXY-8,8,12,16-TETRAMETHYL-3-(2-METHYL-1,3- BENZOTHIAZOL-5-YL)-10-(PROP-2-ENYL)-4,17-DIOXABICYCLO(14.1.0)HEPTADECANE-5,9-DIONE, (1S,3S,7S,10R,11S,12S,16R)-7,11-dihydroxy-8,8,12,16-tetramethyl-3-(2-methyl-1,3-benzothiazol-5-yl)-10-(prop-2-enyl)-4,17-dioxabicyclo(14.1.0)heptadecane-5,9-dione, 4,17-Dioxabicyclo(14.1.0)heptadecane-5,9-dione, 7,11-dihydroxy-8,8,12,16- tetramethyl-3-(2-methyl-5-benzothiazolyl)-10-(2-propenyl)-, (1S,3S,7S,10R,11S,12S,16R)-, 4,17-DIOXABICYCLO(14.1.0)HEPTADECANE-5,9-DIONE, 7,11-DIHYDROXY-8,8,12,16-TETRAMETHYL-3-(2-METHYL-5-BENZOTHIAZOLYL)-10-(2-PROPENYL)-, (1S,3S,7S,10R,11S,12S,16R)-, 7,11-DIHYDROXY-8,8,12,16-TETRAMETHYL-3-(2-METHYL-1,3-BENZOTHIAZOL-5-YL)-10-(PROP-2-EN-1-YL)-4,17-DIOXABICYCLO[14.1.0]HEPTADECANE-5,9-DIONE

Sagopilone is  classified as an: Active Pharmaceutical Ingredient (API) / Pharmaceutical Intermediate